Annie Lambert, PharmD, BCSCP

Annie Lambert, PharmD, BCSCP is Clinical Program Manager for Compliance Solutions at Wolters Kluwer.

Articles by Annie Lambert, PharmD, BCSCP

Q&A: Prepare for FDA Inspection on Compounded GLP-1s

ByAnnie Lambert, PharmD, BCSCP,Luke Halpern, Associate Editor

August 7th 2026

Pharmacists can guide patients in verifying sources, identifying licensed pharmacies, and understanding compounded vs FDA-approved products.

FDA Scrutiny of GLP-1 Compounding Is Just Getting Started, Expert Says

ByAnnie Lambert, PharmD, BCSCP,Luke Halpern, Associate Editor

June 29th 2026

A compliance expert outlines what's next for GLP-1 compounding oversight and how pharmacists can stay audit-ready.

FDA Narrows Compounding Rules for GLP-1s: How Pharmacists Should Respond

ByAnnie Lambert, PharmD, BCSCP,Luke Halpern, Associate Editor

June 24th 2026

A compliance expert breaks down the FDA's move to exclude glucagon-like peptide-1 (GLP-1) drugs from the 503B bulk's list and what it means for pharmacists and patients.

Key Compounding Safety, Compliance, and Technology Challenges Facing Health Systems

ByKennedy Ferruggia, Associate Editor,Annie Lambert, PharmD, BCSCP

December 9th 2025

Pharmacy leaders navigate complex compliance challenges, budget constraints, and evolving technology to enhance safety and efficiency in compounding practices.

Evaluating Compounding Compliance Coming Out of the COVID-19 Fog

ByAnnie Lambert, PharmD, BCSCP

September 3rd 2021

As pharmacists were pulled into patient-facing roles, many hospitals were forced to scale back or make adjustments in medication compounding practices.